Home
Psychiatry
Neurology
Connect with Field Medical
Custom Handout Builder

Search

Search

Home
Psychiatry
Neurology
Connect with Field medical
Custom Handout Builder

Drug Discovery and Development in the Pharmaceutical Industry

Drug Discovery and Development Overview

Drug Discovery

Drug Repurposing

Preclinical Research

Chemistry, Manufacturing and Control

Clinical Research

FDA Review

Post-Market Data Collection

Health Economics and Outcomes Research (HEOR)

Summary

Video Transcript

Speaker: You are all very familiar with this whole process where there is this step-wise approach to developing medicines. We started out with approximately a thousand new discoveries, things that somebody thinks is going to be punitive medicine in the end after they've gone through the discovery process and the preclinical work. The clinical work, we end up with one product. It's a lot of work and a lot of effort that's put into getting to that one product.

There's some estimates. If you look at the references here, this is really a study of a hundred different medicines that have come to the market and what the actual and opportunity costs were. Those costs are estimated to be anywhere between 1.5 and 2.6 and probably a really good estimate around $2 billion that it takes just to bring that medicine to be approved, but then you have to add onto that the costs that are associated with the R&D that is post-approval. That can be several hundred million dollars even post-approval. That's the average for all different kinds of drugs. I believe that because psychiatry studies are a little bit more difficult that the cost for those are actually even higher.

[00:02:02] [END OF AUDIO]

Related Content

Mental Health Primetime: Caring From a Distance

Mental Health Primetime: What Have We Learned From COVID-19

Social Determinants of Health in Serious Mental Illness

View Infographic >

and SUMITOMO PHARMA are trademarks of Sumitomo Pharma Co., Ltd., used under license.
Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co. Ltd.
© 2023 Sumitomo Pharma America, Inc. All rights reserved.
SUNOVIONMEDICAL.COM

You are now leaving fieldmedicalconnect.com

Please confirm below to continue:
I confirm that I am a Health Care Professional (HCP) practicing in the United States, or acting on behalf of an HCP.
OR
I am a Formulary Decision Maker (FDM) and/or working on behalf of a public or private payer organization to review scientific information to make drug or device selection or acquisition, formulary management, or coverage and reimbursement decisions on a population basis.

Field Medical Opt-In

First Name* Last Name* Email*

Zip Code State

Click the therapeutic area(s) you would like more information about: Neurology Psychiatry

By clicking submit, I agree and acknowledge that the information I’ve provided voluntarily will be used only by Sumitomo Pharma and its contracted third-parties to contact me regarding my request. I understand that Sumitomo Pharma will not sell or transfer my name to any third party for their marketing use. Please see the most recent version of our privacy notice, which may change from time to time.

*Required

Share this resource

Your Name* Your Email* Your Friend's Name* Your Friend's Email*

Here’s your message:

Please find a link below to Sunovion Health Insights, a website which contains information intended for U.S. fomulary decision-makers only: www.sunovionhealthinsights.com

The information you provide will be used by Sunovion Pharmaceuticals, Inc. in accordance with our Privacy Policy and by parties acting on behalf of Sunovion to send resources. View our Privacy Notice.